Thomas Flaig
Professor of Medicine-Medical Oncology and Vice Chancellor of Research · University of Colorado School of Medicine
Credentials: · · ·
History
- 2004–2006
- 2000–2003
- 1991–1995
Saint John's University
Research
Increased survival with enzalutamide in prostate cancer after chemotherapy
New England Journal of Medicine · 2012 · 3,725 citations
Abiraterone and increased survival in metastatic prostate cancer
New England Journal of Medicine · 2011 · 3,621 citations
Abiraterone in metastatic prostate cancer without previous chemotherapy
New England Journal of Medicine · 2013 · 2,325 citations
23 papers · 2 as a fellow
20 papers · 1 as a fellow
- LG
16 papers
14 papers
13 papers
12 papers
12 papers
11 papers
Grants
- 2014–2020
Texas EXperimental Cancer Therapeutics Network - TEX CTN
National Cancer Institute · UM1
PI · $759.9K · University of Tx Md Anderson Can Ctr
- 2010–2013
Targeted Nanoparticle Thermoablation for the Treatment of Bladder Cancer
National Cancer Institute · R21
Contact PI · $350.1K · University of Colorado Denver
Clinical trials
- 2022–2036
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
Principal investigator · Recruiting · Early phase 1
University of Colorado, Denver
- 2011–2024
Principal investigator · Completed · Phase 2
SWOG Cancer Research Network
- 2008–2013
Principal investigator · Completed
University of Colorado, Denver
- 2006–2012
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
Principal investigator · Completed · Phase 2
University of Colorado, Denver